Blue sail medical layout structural heart disease field
At 10:47 on December 12, 2018, the first Allegra TM TAVI (transcatheter aortic valve placement) system successfully placed the heart of an 87-year-old patient at Swansea Morriston Hospital in the United Kingdom. Kenneth Graham, vice president of Lanfan Medical and head of Parkson International (Europe), announced that the patient became the first patient in the UK to receive the Allegra TM TAVI system. The success of this operation also means that Lanfan Medical officially entered the structure. The field of sexual heart disease.
At the end of the operation, the patient's condition is stable and the operation is very good. This operation is expected to greatly improve her future quality of life. The patient's preoperative heart valve pressure gradient is greater than 70, and the postoperative pressure gradient is less than 3. Although this is a complicated case, the patient did not experience arrhythmia, vascular or brain surgery complications during the operation, and the procedure lasted only less than two hours.
The surgeon Dr. Smith is very satisfied with the effect of this operation. The patient has severe aortic stenosis, which is a poor prognosis. For elderly patients, hemodynamics caused by aortic stenosis The change is very dangerous, and the implementation of the Allegra? TAVI system can limit the hemodynamic changes of aortic stenosis after surgery. During the surgery, the surgeon was very impressed with the technology, ease of use and safety benefits of Allegra®.
It is understood that the Allegra TM valve is laser-cut self-expanding Nitinol stent structure, and the bovine pericardium biological valve is manually installed. Surgery has proven the long-term effects of bovine pericardium. The Allegra TM valve is fitted with six radiopaque gold markers that provide excellent visual results during placement.
Allegra TM valve
After the first successful operation, the Allegra TM TAVI system will be placed in more patients around the world, which will greatly improve the quality of life of patients and help more patients benefit.
July 1, 2018, Blue Sail's heart and brain health platform Biosensors Division inter-reaching distribution agreement TAVI system Allegra, Allegra TM TAVI system uses a new valve technology (NVT - Muri, Switzerland)? Development and manufacturing. Li Bingrong, President of Lanfan Medical, stressed that this is a milestone in our partnership and cooperation with NVT. We look forward to continuing to work together to successfully expand into other markets in the UK and Ireland TAVI markets, and to bring the most advanced medical devices and treatments in the world. Brought back to China.
Li Bingrong said, "The success of this operation marks the official entry of Lanfan Medical into the field of structural heart disease. In the future, we will continue to enrich our product line and strive to become a global solution provider in the cardiovascular field!"
In November 2016, the “13th Five-Year Plan for the Development of Pharmaceutical Industry†jointly drafted by the six ministries and commissions of the country listed implanted products and medical materials as one of the six key development areas. The "Planning" clearly proposes to accelerate the application of new materials technology, and continue to accelerate the innovation and industrialization of new medical device products in the field of degradable vascular stents, artificial valves and other interventional treatments for clinical treatment needs such as cardiology. With the aging of the population, the rapid growth of patients with cardiovascular diseases and the growing awareness of public health management, interventional devices for structural heart disease will usher in rapid growth opportunities, with huge market capacity and bright prospects.
Lanfan Medical has seized this wave of air outlets. As a leading medical device with a complete layout of low-value consumables and high-value consumables, Lanfan Medical's main products include medical gloves, health protective gloves, first-aid kits, medical dressings and other medical protective products. The global market share of the fist products PVC gloves is 22%. The main products of the high value consumables segment are cardiac stents and interventional cardiac surgery related devices. Its business is operated by Singapore Parkson International and has operations in more than 90 countries around the world. The world of cardiac stents ranks fourth in the world.
In the future, Lanfan Medical will continue to deepen the research and development, production and sales of cardiovascular related medical devices. The interventional device field that has entered the structural heart disease will undoubtedly open up new developments for the company's long-term development. growth point.
Filter Mesh
Filter mesh including metal filter mesh,ventilation filter mesh, air conditoner filter mesh, shale shaker screen,mine sieving mesh, dutch weave filter mesh, reverse dutch weave wire cloth, metal fiber sintered felt.
The filter mesh be made from different mesh of metal mesh, the application is filter impurities and improve mixing and plasticizing effect.
The advantages of filter mesh is anti-acid, anti-alkali, temperature, wear-resistant, corrosion, etc. It be maindly used in mining, oil, chemical, food, medicine, machinery manufacturing and other industries.
Filter Mesh,Filter Cartridge,Filter Tube,Stainless Steel Filter Mesh,Crimped Wire Mesh
ANPING COUNTY SHANGCHEN WIREMESH PRODUCTS CO.,LTD , https://www.scwpwiremesh.com